标题
Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease
作者
关键词
-
出版物
BMC Nephrology
Volume 18, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-12-01
DOI
10.1186/s12882-017-0688-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
- (2016) Iain C. Macdougall et al. KIDNEY INTERNATIONAL
- A randomized trial of intravenous and oral iron in chronic kidney disease
- (2015) Rajiv Agarwal et al. KIDNEY INTERNATIONAL
- A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia
- (2015) Philip A. Kalra et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management
- (2014) D. Rampton et al. HAEMATOLOGICA
- Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients
- (2014) Takahiro Kuragano et al. KIDNEY INTERNATIONAL
- Distinct immunologic effects of different intravenous iron preparations on monocytes
- (2014) Lisa H. Fell et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
- (2014) I. C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
- (2013) Suetonia C. Palmer ANNALS OF INTERNAL MEDICINE
- Infection Risk with Bolus versus Maintenance Iron Supplementation in Hemodialysis Patients
- (2013) M. A. Brookhart et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement
- (2013) Francesco Locatelli et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Intravenous Iron Supplementation Practices and Short-Term Risk of Cardiovascular Events in Hemodialysis Patients
- (2013) Abhijit V. Kshirsagar et al. PLoS One
- Iron and Infection in Hemodialysis Patients
- (2013) Julie H. Ishida et al. SEMINARS IN DIALYSIS
- Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI Study
- (2012) Guy Rostoker et al. AMERICAN JOURNAL OF MEDICINE
- Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron
- (2012) Hussam Ghoti et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Notice
- (2012) Kidney International Supplements
- Correction of Postkidney Transplant Anemia Reduces Progression of Allograft Nephropathy
- (2011) G. Choukroun et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
- (2010) J. D. Rizzo et al. BLOOD
- The struggle for iron - a metal at the host-pathogen interface
- (2010) Manfred Nairz et al. CELLULAR MICROBIOLOGY
- Serum Iron Markers Are Inadequate for Guiding Iron Repletion in Chronic Kidney Disease
- (2010) P. Ferrari et al. Clinical Journal of the American Society of Nephrology
- Comparative Mortality Risk of Anemia Management Practices in Incident Hemodialysis Patients
- (2010) M. Alan Brookhart JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp(R) Therapy (TREAT) Study
- (2010) F. Locatelli et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Iron in innate immunity: starve the invaders
- (2009) Tomas Ganz CURRENT OPINION IN IMMUNOLOGY
- A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment
- (2009) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
- Relative risk of death in UK haemodialysis patients in relation to achieved haemoglobin from 1999 to 2005: an observational study using UK Renal Registry data incorporating 30,040 patient-years of follow-up
- (2009) I. C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Erythropoietin, Iron Depletion, and Relative Thrombocytosis: A Possible Explanation for Hemoglobin-Survival Paradox in Hemodialysis
- (2008) Elani Streja et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Anemia of chronic disease: A harmful disorder or an adaptive, beneficial response?
- (2008) R. Zarychanski et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Pure Red Cell Aplasia Induced by Erythropoiesis-Stimulating Agents
- (2008) C. Pollock et al. Clinical Journal of the American Society of Nephrology
- Combined High Serum Ferritin and Low Iron Saturation in Hemodialysis Patients: The Role of Inflammation
- (2008) M. Rambod et al. Clinical Journal of the American Society of Nephrology
- Nramp1-functionality increases iNOS expressionviarepression of IL-10 formation
- (2008) Gernot Fritsche et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation